237 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 5 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HPRT1Hypoxanthine phosphoribosyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
HSD3B1Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
IDEInsulin-degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
IGF1RInsulin-like growth factor 1 receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
Expressed in all
IKBKBInhibitor of kappa light polypeptide gene enhancer in B-cells, kinase betaDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
IMPDH1IMP (inosine 5'-monophosphate) dehydrogenase 1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
IMPDH2IMP (inosine 5'-monophosphate) dehydrogenase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
Expressed in all
JAK1Janus kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
JAK2Janus kinase 2Cancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
JAK3Janus kinase 3Cancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
KDRKinase insert domain receptor (a type III receptor tyrosine kinase)Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
LCKLCK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
LIPFLipase, gastricEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
LPLLipoprotein lipaseCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Group enriched
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAPK11Mitogen-activated protein kinase 11Enzymes
FDA approved drug targets
Predicted intracellular proteins
Mixed
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
METMET proto-oncogene, receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
MGAMMaltase-glucoamylase (alpha-glucosidase)Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
MMEMembrane metallo-endopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MMP1Matrix metallopeptidase 1 (interstitial collagenase)Cancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MMP10Matrix metallopeptidase 10 (stromelysin 2)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP11Matrix metallopeptidase 11 (stromelysin 3)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP12Matrix metallopeptidase 12 (macrophage elastase)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP13Matrix metallopeptidase 13 (collagenase 3)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
MMP14Matrix metallopeptidase 14 (membrane-inserted)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
MMP15Matrix metallopeptidase 15 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
MMP16Matrix metallopeptidase 16 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MMP17Matrix metallopeptidase 17 (membrane-inserted)Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
MMP19Matrix metallopeptidase 19Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP2Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
MMP20Matrix metallopeptidase 20Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Not detected
MMP21Matrix metallopeptidase 21Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP23BMatrix metallopeptidase 23BEnzymes
FDA approved drug targets
Predicted intracellular proteins
Mixed
MMP24Matrix metallopeptidase 24 (membrane-inserted)Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
MMP25Matrix metallopeptidase 25Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
MMP26Matrix metallopeptidase 26Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP27Matrix metallopeptidase 27Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP28Matrix metallopeptidase 28Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Mixed
MMP3Matrix metallopeptidase 3 (stromelysin 1, progelatinase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Group enriched
MMP7Matrix metallopeptidase 7 (matrilysin, uterine)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MMP8Matrix metallopeptidase 8 (neutrophil collagenase)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched

« prev | Page of 5 | next »